VRK1 is highly expressed in many tumor types (Martin et al., 2008) and confers resistance to genotoxic treatments in different tumors (Peters et al., 2005; Salzano et al., 2014; Liu et al., 2017; Jarman et al., 2018). Here, VRK1 is linked to neoplasm.